AR051797A1 - Derivados de hidantoina inhibidores de metaloproteinasas - Google Patents
Derivados de hidantoina inhibidores de metaloproteinasasInfo
- Publication number
- AR051797A1 AR051797A1 ARP050105275A ARP050105275A AR051797A1 AR 051797 A1 AR051797 A1 AR 051797A1 AR P050105275 A ARP050105275 A AR P050105275A AR P050105275 A ARP050105275 A AR P050105275A AR 051797 A1 AR051797 A1 AR 051797A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydantoin derivatives
- metaloproteinase inhibitors
- metaloproteinase
- inhibitors
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente se refiere a una formula (1) en donde R1 es un C2-4 alquilo y está sustituido con dos o más grupos fluor y R2 es metilo o etilo, o una sal aceptable para uso farmacéutico del mismo; procesos para su preparacion, composiciones farmacéuticas que los contienen y su uso en el tratamiento de enfermedades o estados clínicos mediados por enzimas metaloproteinasa.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0427403.1A GB0427403D0 (en) | 2004-12-15 | 2004-12-15 | Novel compounds I |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR051797A1 true AR051797A1 (es) | 2007-02-07 |
Family
ID=34090044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050105275A AR051797A1 (es) | 2004-12-15 | 2005-12-15 | Derivados de hidantoina inhibidores de metaloproteinasas |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8129412B2 (es) |
| EP (1) | EP1828166B1 (es) |
| JP (1) | JP5042849B2 (es) |
| KR (1) | KR20070090921A (es) |
| CN (1) | CN101080402B (es) |
| AR (1) | AR051797A1 (es) |
| AU (1) | AU2005315459B2 (es) |
| BR (1) | BRPI0519057A2 (es) |
| CA (1) | CA2589525A1 (es) |
| CY (1) | CY1109376T1 (es) |
| DE (1) | DE602005015617D1 (es) |
| DK (1) | DK1828166T3 (es) |
| ES (1) | ES2328836T3 (es) |
| GB (1) | GB0427403D0 (es) |
| HK (1) | HK1108435A1 (es) |
| HR (1) | HRP20090489T1 (es) |
| IL (1) | IL183590A0 (es) |
| MX (1) | MX2007006744A (es) |
| NO (1) | NO20073550L (es) |
| NZ (1) | NZ555684A (es) |
| PL (1) | PL1828166T3 (es) |
| PT (1) | PT1828166E (es) |
| RS (1) | RS51193B (es) |
| RU (1) | RU2388758C2 (es) |
| SA (1) | SA05260406B1 (es) |
| SI (1) | SI1828166T1 (es) |
| TW (1) | TW200634001A (es) |
| UA (1) | UA89067C2 (es) |
| WO (1) | WO2006064218A1 (es) |
| ZA (1) | ZA200705068B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2610258T3 (pl) | 2007-10-19 | 2015-02-27 | Boehringer Ingelheim Int | Podstawione piperydyno-dihydrotienopirymidyny |
| WO2009138777A1 (en) * | 2008-05-12 | 2009-11-19 | Astrazeneca Ab | Process for the preparation of alkoxy-phenoxy-pi peridine |
| US7759512B2 (en) | 2008-07-21 | 2010-07-20 | 3M Innovative Properties Company | Aqueous methods for making fluorinated sulfonate esters |
| CN102234287B (zh) | 2010-04-26 | 2015-08-05 | 上海阳帆医药科技有限公司 | 硝基咪唑类化合物、其制备方法和用途 |
| US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
| EP3056486B1 (en) | 2010-07-16 | 2018-07-11 | AbbVie Ireland Unlimited Company | Process for preparing intermediates for antiviral compounds |
| MX338725B (es) | 2010-07-16 | 2016-04-28 | Abbvie Bahamas Ltd | Ligando de fosfina para reacciones cataliticas. |
| US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| HUP1300139A2 (en) | 2013-03-06 | 2014-09-29 | Richter Gedeon Nyrt | Phenoxypiperidine h3 antagonists |
| US20160364553A1 (en) * | 2015-06-09 | 2016-12-15 | Intel Corporation | System, Apparatus And Method For Providing Protected Content In An Internet Of Things (IOT) Network |
| GB201610056D0 (en) * | 2016-06-09 | 2016-07-27 | Galapagos Nv And Laboratoires Servier Les | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9919776D0 (en) | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
| NZ515829A (en) | 1999-06-04 | 2003-10-31 | Astrazeneca Ab | Inhibitors of metalloproteinases |
| WO2001062742A1 (en) | 2000-02-21 | 2001-08-30 | Astrazeneca Ab | Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| SE0301922D0 (sv) | 2003-06-27 | 2003-06-27 | Astrazeneca Ab | Novel compounds |
-
2004
- 2004-12-15 GB GBGB0427403.1A patent/GB0427403D0/en not_active Ceased
-
2005
- 2005-12-14 WO PCT/GB2005/004811 patent/WO2006064218A1/en active Application Filing
- 2005-12-14 MX MX2007006744A patent/MX2007006744A/es active IP Right Grant
- 2005-12-14 UA UAA200706159A patent/UA89067C2/ru unknown
- 2005-12-14 NZ NZ555684A patent/NZ555684A/en not_active IP Right Cessation
- 2005-12-14 CA CA002589525A patent/CA2589525A1/en not_active Abandoned
- 2005-12-14 KR KR1020077013343A patent/KR20070090921A/ko not_active Application Discontinuation
- 2005-12-14 SI SI200530774T patent/SI1828166T1/sl unknown
- 2005-12-14 BR BRPI0519057-6A patent/BRPI0519057A2/pt not_active IP Right Cessation
- 2005-12-14 ES ES05818265T patent/ES2328836T3/es active Active
- 2005-12-14 PT PT05818265T patent/PT1828166E/pt unknown
- 2005-12-14 DE DE602005015617T patent/DE602005015617D1/de active Active
- 2005-12-14 SA SA05260406A patent/SA05260406B1/ar unknown
- 2005-12-14 EP EP05818265A patent/EP1828166B1/en active Active
- 2005-12-14 CN CN2005800432057A patent/CN101080402B/zh not_active Expired - Fee Related
- 2005-12-14 RU RU2007121222/04A patent/RU2388758C2/ru not_active IP Right Cessation
- 2005-12-14 DK DK05818265T patent/DK1828166T3/da active
- 2005-12-14 US US11/793,358 patent/US8129412B2/en not_active Expired - Fee Related
- 2005-12-14 PL PL05818265T patent/PL1828166T3/pl unknown
- 2005-12-14 RS RSP-2009/0397A patent/RS51193B/sr unknown
- 2005-12-14 AU AU2005315459A patent/AU2005315459B2/en not_active Ceased
- 2005-12-14 JP JP2007546173A patent/JP5042849B2/ja not_active Expired - Fee Related
- 2005-12-15 TW TW094144382A patent/TW200634001A/zh unknown
- 2005-12-15 AR ARP050105275A patent/AR051797A1/es not_active Application Discontinuation
-
2007
- 2007-05-31 IL IL183590A patent/IL183590A0/en unknown
- 2007-06-12 ZA ZA200705068A patent/ZA200705068B/xx unknown
- 2007-07-09 NO NO20073550A patent/NO20073550L/no not_active Application Discontinuation
-
2008
- 2008-03-04 HK HK08102383.3A patent/HK1108435A1/xx not_active IP Right Cessation
-
2009
- 2009-09-15 HR HR20090489T patent/HRP20090489T1/hr unknown
- 2009-09-17 CY CY20091100960T patent/CY1109376T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR051797A1 (es) | Derivados de hidantoina inhibidores de metaloproteinasas | |
| AR073138A1 (es) | Derivados de dioxa-biciclo (3.2.1) octano- 2,3,4-triol | |
| AR055076A1 (es) | Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica. | |
| TN2010000026A1 (fr) | Nouveaux derives de 6-triazolopyridazine-sulfanyl benzothiazole et benzimidazole, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met | |
| UY30649A1 (es) | Compuestos de biaril éter urea | |
| MA35749B1 (fr) | Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc | |
| RS53209B (en) | PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS C PROTEASE INHIBITOR | |
| AR060631A1 (es) | Derivados de pirimidina y su uso como inhibidores de fosfatidilnositol 3-quinasa (pi3k) | |
| BRPI0721905B8 (pt) | composto inibidor de proteassoma, sua composição farmacêutica e seu uso | |
| AR051795A1 (es) | Derivados de hidantoina inhibidores de metaloproteinasas | |
| GT200800242A (es) | Derivados biciclicos como inhibidores de cetp | |
| AR048213A1 (es) | 1-(4-mono-y di-halometilsulfonilfenil)-2-acilamino-fluorpropanoles analogos al florfenicol | |
| AR049274A1 (es) | Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2 | |
| AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
| UY27740A1 (es) | Nuevos compuestos | |
| BRPI0518993A2 (pt) | composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| AR061238A1 (es) | Compuestos de oxilmilo macrociclico inhibidores de proteasa de hepatitis c | |
| ECSP088974A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| AR061134A1 (es) | Derivados de tioxantina | |
| ECSP099370A (es) | Derivados de hidantoína usados como inhibidores de mmp | |
| AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
| UY29085A1 (es) | Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes | |
| AR066972A1 (es) | Derivados azapeptidicos | |
| UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |